Susan Laura Smith, SVP & CHIEF COMMERCIAL OFFICER at Y-mAbs Therapeutics, Inc. (YMAB), sold 1,682 shares at $16.55 ($28K) on 2024-03-05, disclosed to the SEC on 2024-03-07.
Open-market sale of $28k YMAB by SVP & CHIEF COMMERCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.